-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-5-protocol-update-2023.pdf
January 01, 2023 - systematic reviews, meta-analyses, or other cross-study comparisons; (2) help identify research
gaps to determine … Process for Selecting Studies: PICOTS described in Section II and criteria in Table 1 will be used
to determine … One investigator will determine
eligibility at the title/abstract review stage and a second investigator
-
effectivehealthcare.ahrq.gov/sites/default/files/selection-of-data-sources-chapter-8.pptx
January 01, 2013 - Registry data can be used for public health surveillance, to determine incidence rates, to perform risk … case-control studies, where selection is based on a disease or condition and participants are contacted to determine … the information collected, registry data can potentially be used for public health surveillance, to determine
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_10-user-guide-to-ocer_130129.pdf
January 01, 2011 - Modeling
Approach
The forms of the study outcome, exposure of
interest, and study covariates will determine … Guidance Key Considerations Check
Describe the key variables of interest
with regard to factors that determine … covariates, distributions or
graphs that are needed to decide if transformation of
data is needed or to determine
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-selection-harms-systematic-reviews.pdf
February 01, 2018 - So how should the systematic reviewer determine the harms of greatest importance to include? … Key Messages (I): Harms are
Important But Not All Can be Included
• Harms are vitally important to determine … Notes
Key Messages (I): Harms are Important But Not All Can be Included�Harms are vitally important to determine
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1306.pdf
June 01, 2013 - Those impressions are used
to determine potential impact. … of exacerbations received azithromycin 250 mg daily or placebo for 1 year besides
standard care to determine … exacerbations received azithromycin 250 mg daily (n=570) or placebo (n=572) for 1 year plus
standard care to determine
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypertension-drugs-utilization_research.pdf
January 25, 2011 - Utilization of antihypertensive drug classes among
Medicare beneficiaries with hypertension, 2007 to 2009
Cardiovascular Issues Data Points #8
Between 2007 and 2009,
87 to 88 percent of Medicare
beneficiaries with hypertension
used at least one prescription
for an antihypertensive drug.
Beneficiaries with hyp…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-balancing-harms-benefits_research-2012.pdf
January 01, 2012 - Determine the role of values and preferences in assessing benefits and harms across
each step of a … The team also
evaluated articles citing any of the above articles to determine whether they described … To conduct an
assessment of benefits and harms, reviewers must determine if the surrogate has been … Investigator choices
may also determine: (1) whether investigators conduct a quantitative benefit harm … Assumptions should be justified to enable end users to determine whether the assumptions fit
their
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-screening_executive.pdf
April 01, 2012 - SAP uses a white light stimulus on a white background
to determine threshold values. … Each item
query required a “yes,” “no,” or “unable to determine/not
reported” response. … methodological quality of systematic reviews.9
We used the following criteria, adapted from Li, to
determine … As we are
unable to determine which parameters are most important
for identifying persons with OAG … FDT, noncontact
tonometry, and a questionnaire individually and in all
possible combinations to determine
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cesarean-birth-future_research.pdf
August 09, 2012 - • Surveillance to determine important long-term clinical outcomes of VBAC, emergent
cesarean, or … Surveillance to determine long-term maternal and infant clinical outcomes of TOL
compared with ERCD. … Surveillance to determine long-term maternal and infant
clinical outcomes of TOL vs. … Using the
Delphi technique to determine which outcomes to
measure in clinical trials: recommendations … Surveillance to determine long term maternal and infant clinical outcomes of TOL vs.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioid-use-disorder_research-protocol.pdf
February 24, 2016 - This technical brief is intended to help determine the
scope of future research, such as a subsequent … For abstracts without adequate information to determine inclusion or
exclusion, we will retrieve the
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
August 01, 2012 - patients to either an innovator or
generic product in a parallel fashion so they
cannot be used to determine … seizure injury,
and status epilepticus endpoints were unavailable
or did not allow adequate data to determine … However, our
data do not allow us to determine if an individual
patient or subset of patients would … patients to either an
innovator or generic product in a parallel fashion so they
cannot be used to determine … However, our data do not allow us to determine if an
individual patient or subset of patients would
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
August 01, 2012 - patients to either an innovator or
generic product in a parallel fashion so they
cannot be used to determine … seizure injury,
and status epilepticus endpoints were unavailable
or did not allow adequate data to determine … However, our
data do not allow us to determine if an individual
patient or subset of patients would … patients to either an
innovator or generic product in a parallel fashion so they
cannot be used to determine … However, our data do not allow us to determine if an
individual patient or subset of patients would
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-economics_research.pdf
January 01, 2011 - were estimated to cost U.S. health care payers $11
billion.5 Although much effort has been made to determine
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-cough_disposition-comments.pdf
January 07, 2013 - responsiveness of the Punum ladder was studied rather than the
CQLQ.
4) On page 74, I was able to determine
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/white-paper-framework-for-conceptualizing-evidence-needs_0.pdf
December 01, 2017 - question(s) of
interest; tools to promote the use of evidence; and a feedback or auditing mechanism to
determine … Ellen 201445,46 201347 used surveys and qualitative studies to determine the barriers and
facilitators … evidence
synthesis program or by the health system), and finally a
• feedback or auditing mechanism to determine … their partnerships with health systems
to better understand their evidence synthesis needs and to determine … developed comparing the technology
and alternative strategies; value of information analysis
performed to determine
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_disposition-comments.pdf
March 01, 2012 - be most unfortunate if the flawed
overall conclusions were used to direct heath care policy or to
determine … During the topic
refinement phase we engaged a variety of
stakeholders to determine the questions and … The major issue in treating
patients with epilepsy is to determine the AED that is most
effective in … Unfortunately, there is little information
available to determine which specific individuals might have … That said, we have
no ability to determine a priori which patients would be negatively
affected by
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/transitions-care-pediatric-to-adult-services-disposition-comments.pdf
May 31, 2022 - 3 that “currently,
stakeholders have little to rely on beyond local
and institutional policies to determine … stakeholders must rely on institutional policies and
professional organization position statements to determine … Initiatives are
needed to determine the scope of the work
involved in transition care planning and … Initiatives are
needed to determine the scope of the work
involved in transition care planning and … We now highlight in the discussion of Chapter 11
that ”Initiatives are needed to determine the scope
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/accountable-care-registries-guide-3rd-ed-addendum-white-paper-2018-5.pdf
January 01, 2018 - For instance, to determine advanced
chronic kidney disease, two glomerular filtration rate (GFR) results … It is important that organizations working towards
accountable care determine what risk they are attempting … Care planning
can also determine data and interoperability standards; this could include patient diagnosis … where they can examine their own compliance with measures, as well as drill down to detailed
lists to determine … Specifically, NCQA requests reports on core performance and
patient experience measures to determine
-
effectivehealthcare.ahrq.gov/sites/default/files/back-pain-treatment_disposition-comments.pdf
February 29, 2016 - We do not
think it is appropriate to determine
effectiveness based on change
from baseline without … This is important to determine the
generalizability of findings to others with
pain, the potential … In general, there was
insufficient evidence to determine
how patient factors predict
responsiveness … As noted in the
Discussion, more research is
needed to determine factors that
predict responsiveness … In general, there was
insufficient evidence to determine
how patient factors predict
responsiveness
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-249-malnutrition-disposition-comments_0_0.pdf
October 13, 2021 - have
noted that there is significant overlap amongst tools
and therefore, future research could also determine … have
noted that there is significant overlap amongst tools
and therefore, future research could also determine … Future
Research now includes the following language:
“One way to indirectly address this is to determine … All screening tools should be validated
against a diagnostic gold standard in order to
determine sensitivity … and specificity, and then
studied in clinical practice to determine clinical
effectiveness.